These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33547742)

  • 1. Acylated ghrelin protects against doxorubicin-induced nephropathy by activating silent information regulator 1.
    Shati AA; El-Kott AF
    Basic Clin Pharmacol Toxicol; 2021 Jun; 128(6):805-821. PubMed ID: 33547742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylated ghrelin prevents doxorubicin-induced cardiac intrinsic cell death and fibrosis in rats by restoring IL-6/JAK2/STAT3 signaling pathway and inhibition of STAT1.
    Shati AA; El-Kott AF
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1151-1168. PubMed ID: 31093684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylated Ghrelin Protects the Hearts of Rats from Doxorubicin-Induced Fas/FasL Apoptosis by Stimulating SERCA2a Mediated by Activation of PKA and Akt.
    Shati AA; Dallak M
    Cardiovasc Toxicol; 2019 Dec; 19(6):529-547. PubMed ID: 31093930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acylated ghrelin suppresses doxorubicin-induced testicular damage and improves sperm parameters in rats via activation of Nrf2 and mammalian target of rapamycin.
    Shati AA; Khalil MA
    J Cancer Res Ther; 2023; 19(5):1194-1205. PubMed ID: 37787283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylated Ghrelin Attenuates l-Thyroxin-induced Cardiac Damage in Rats by Antioxidant and Anti-inflammatory Effects and Downregulating Components of the Cardiac Renin-angiotensin System.
    Badi R
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):422-436. PubMed ID: 34132689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexrazoxane Alleviated Doxorubicin-Induced Nephropathy in Rats.
    Hu H; Xie C; Weng Z; Yu P; Wang Y; Shan L
    Pharmacology; 2022; 107(3-4):206-215. PubMed ID: 35021174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoliquiritigenin prevents Doxorubicin-induced hepatic damage in rats by upregulating and activating SIRT1.
    Al-Qahtani WH; Alshammari GM; Ajarem JS; Al-Zahrani AY; Alzuwaydi A; Eid R; Yahya MA
    Biomed Pharmacother; 2022 Feb; 146():112594. PubMed ID: 34968927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protection afforded by Berberine against chemotherapy-mediated nephropathy in rats involves regulation of the antioxidant axis.
    Alagal RI; AlFaris NA; Alshammari GM; ALTamimi JZ; AlMousa LA; Yahya MA
    Basic Clin Pharmacol Toxicol; 2023 Jan; 132(1):98-110. PubMed ID: 36221996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective impact of berberine against doxorubicin-induced nephrotoxicity in rats.
    Ibrahim Fouad G; Ahmed KA
    Tissue Cell; 2021 Dec; 73():101612. PubMed ID: 34371291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin alleviates cadmium chloride-induced renal damage in rats by suppressing endoplasmic reticulum stress through SIRT1-dependent deacetylation of Xbp-1s and eIF2α.
    Alshammari GM; Al-Qahtani WH; AlFaris NA; Albekairi NA; Alqahtani S; Eid R; Yagoub AEA; Al-Harbi LN; Yahya MA
    Biomed Pharmacother; 2021 Sep; 141():111862. PubMed ID: 34246189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ellagic acid protects against diabetic cardiomyopathy in rats by stimulating cardiac silent information regulator 1 signaling.
    Altamimi JZ; Alfaris NA; Alshammari GM; Alagal RI; Aljabryn DH; Aldera H; Alkhateeb MA; Yahya MA
    J Physiol Pharmacol; 2020 Dec; 71(6):. PubMed ID: 33901999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.
    Guo NF; Cao YJ; Chen X; Zhang Y; Fan YP; Liu J; Chen XL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4017-4026. PubMed ID: 31115031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway.
    El-Kott AF; Shati AA; Al-Kahtani MA; Alqahtani S
    Anal Cell Pathol (Amst); 2019; 2019():9627810. PubMed ID: 31360627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity
    Song S; Chu L; Liang H; Chen J; Liang J; Huang Z; Zhang B; Chen X
    Front Pharmacol; 2019; 10():1030. PubMed ID: 31572199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fuzheng Huayu Formula () prevents rat renal interstitial fibrosis induced by HgCl
    Yuan JL; Tao YY; Wang QL; Shen L; Liu CH
    Chin J Integr Med; 2017 Aug; 23(8):598-604. PubMed ID: 28197934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats.
    Kuzu M; Yıldırım S; Kandemir FM; Küçükler S; Çağlayan C; Türk E; Dörtbudak MB
    Chem Biol Interact; 2019 Aug; 308():89-100. PubMed ID: 31100273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eriodictyol attenuates doxorubicin-induced nephropathy by activating the AMPK/Nrf2 signalling pathway.
    Badi RM; Khaleel EF; Satti HH; Monir R
    J Tradit Complement Med; 2024 Mar; 14(2):203-214. PubMed ID: 38481546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
    Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J
    Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway.
    Wu YZ; Zhang L; Wu ZX; Shan TT; Xiong C
    Oxid Med Cell Longev; 2019; 2019():2150394. PubMed ID: 31885776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective mechanisms of protocatechuic acid against doxorubicin-induced nephrotoxicity in rat model.
    Molehin OR; Adeyanju AA; Adefegha SA; Oyeyemi AO; Idowu KA
    J Basic Clin Physiol Pharmacol; 2019 Jul; 30(4):. PubMed ID: 31280244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.